Cart summary

You have no items in your shopping cart.

Gefitinib hydrochloride

SKU: orb1909577

Description

Gefitinib hydrochloride is a potent and selective oral EGFR tyrosine kinase inhibitor. It is widely used in oncology research to study its antitumor effects, including the inhibition of EGF-driven cell proliferation, induction of autophagy, and modulation of inflammation and fibrosis in both cellular and animal models.

Research Area

Cardiovascular Research, Signal Transduction

Images & Validation

Key Properties

CAS Number184475-55-6
MW483.36
Purity99.80% (May vary between batches)
FormulaC22H25Cl2FN4O3
SMILESCl.FC1=CC=C(C=C1Cl)NC=2N=CN=C3C=C(OC)C(OCCCN4CCOCC4)=CC32
TargetEGFR
SolubilityDMSO:< 0.1 mg/mL (insoluble);H2O:4 mg/mL (8.28 mM)

Bioactivity

Target IC50
GLC82 cells:2 μM|non-transformed cells:20 nM|Calu3 (cells):2 μM
In Vivo
Gefitinib hydrochloride (150 mg/kg, orally) in combination with metformin significantly inhibited the growth of tumor xenografts formed by subcutaneous transplantation of H1299 or CALU-3 GEF-R cells in nude mice. In rats treated with radiation therapy, Gefitinib hydrochloride exacerbated the inflammatory response in the lungs, including the infiltration of inflammatory cells and the increase of pro-inflammatory factors, whereas Gefitinib hydrochloride served to slow down the fibrotic remodeling of the lungs by inhibiting the proliferation of lung fibroblasts.
In Vitro
Gefitinib hydrochloride (0.01-0.1 mM) increased phosphotyrosine loading of the receptor by inducing EGFRvIII dimerization, enhanced ERK signaling, and stimulated cell proliferation and anchorage-independent growth, especially upon prolonged exposure of EGFRvIII-expressing cells. In contrast, Gefitinib hydrochloride (1-2 mM) significantly reduced phosphotyrosine loading of EGFRvIII and inhibited EGFRvIII-mediated proliferation and anchorage-independent growth. Gefitinib hydrochloride inhibited monolayer growth of non-transformed cells driven by EGF with an IC50 of 20 nM. Gefitinib hydrochloride also inhibited the proliferation of CALU-3 and GLC82 cells with an IC50 of 2 μM.

Storage & Handling

Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

ZD1839 hydrochloride, ZD-1839 hydrochloride, EGFR

Similar Products

Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Gefitinib hydrochloride (orb1909577)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

50 mg
$ 80.00
100 mg
$ 90.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry